SCHEMBL25837854

SCHEMBL25837854

CCc1cn(-c2nccc(CNC(=O)OC(C)(C)C)n2)cn1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA9 Q16790 3/20 0.39
CA12 O43570 2/20 0.39
MAPKAPK2 P49137 1/20 0.37
KDM4A O75164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
BRD4 O60885 3/20 0.36
CA4 P22748 1/20 0.36
CA7 P43166 1/20 0.36
PCSK9 Q8NBP7 1/20 0.35
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
NAMPT P43490 1/20 0.34
ACHE P22303 1/20 0.34
SREBF2 Q12772 1/20 0.34
ATR Q13535 1/20 0.34
BCHE P06276 1/20 0.34
CPB2 Q96IY4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21366346 0.87 CA1 (0.37) CA1CA2CA9CA12KDM4A
SCHEMBL21365984 0.85 CA1 (0.38) CA1CA2CA9CA12KDM4A
SCHEMBL25837814 0.81 L3MBTL1 (0.40) CA1CA2CA9CA12MAPKAPK2
SCHEMBL445560 0.74 STK17B (0.48) CA1CA2CA9CA12MAPKAPK2
SCHEMBL23795924 0.73 KDM4A (0.41) CA1CA2CA9CA12KDM4A
SCHEMBL25837853 0.73 RPS6KA5 (0.38) L3MBTL1
SCHEMBL23795985 0.73 KDM4A (0.42) CA1CA2CA9CA12KDM4A
SCHEMBL30290047 0.72 KDM4A (0.41) CA1CA2CA9CA12KDM4A
SCHEMBL28606906 0.72 KDM4A (0.41) CA1CA2CA9CA12KDM4A
SCHEMBL28620381 0.72 KDM4A (0.41) CA1CA2CA9CA12KDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691967-B2 Antibiotics effective for gram-negative pathogens THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2023-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691967-B2 Antibiotics effective for gram-negative pathogens PGLS, MGAM, GMDS CA1 4851/4885CA2 4217/4885CA9 3522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.